Departure and appointment · 8 October 2026
ANGIODYNAMICS INC
ANGO · Listed
Key facts
- How the CEO left
- Retirement
- Planned or abrupt
- Planned
- Successor
- External hire
- Outgoing CEO stays as
- Adviser
- Signs it was forced
- None stated
- Other news alongside
- None
- Effective
- 2 November 2026
- Reason given
- retirement
Read from the filing and press release by a language model (Google Gemini), told to use only that text. It can make mistakes; the quotes below are the source.
The announcement
CEO Appointment As previously disclosed, James C. Clemmer has announced his intention to retire from his position as the President and Chief Executive Officer of the Company on the earlier of November 30, 2026 and appointment of a successor Chief Executive Officer.
On October 2, 2026, the Board of Directors of the Company (the “ Board ”) appointed Eric Honroth to serve as President and Chief Executive Officer of the Company, effective as of November 2, 2026 (the “ Effective Date ”) and concurrently with Mr. Clemmer’s retirement.
In addition, Mr. Honroth was appointed as a director on the Company’s Board as of the Effective Date, conditioned upon his commencement of service as President and Chief Executive Officer and concurrently with Mr. Clemmer’s retirement from his position as a member of the Board.
There is no arrangement or understanding between Mr. Honroth and any other person pursuant to which Mr. Honroth was appointed to serve as the Company’s President and Chief Executive Officer or a member of the Board, and there are no transactions to which Mr. Honroth has a direct or indirect material interest requiring disclosure under Item 404(a) of Regulation S-K. Honroth Employment Agreement In connection with Mr. Honroth’s appointment as President and Chief Executive Officer, on October 3, 2026, the Company and Mr. Honroth entered into the Employment Agreement.
Sentences matched by our CEO change rules, from the first filing. Read the 8-K on SEC EDGAR ↗
Share price reaction
The filing reached SEC EDGAR on 8 October 2026 at 11:16 New York time, during trading hours, so day 0 is that same day. Day 0 is marked by the vertical line.
| Window | ANGO | S&P 500 | Abnormal |
|---|---|---|---|
| Days 0 to +1 | −18.8% | +0.2% | −18.7% |
| Days 0 to +3 | −23.2% | +0.1% | −24.3% |
| 1 month (days 0 to +21)so far, 14 of 22 days | −13.6% | −1.0% | −12.3% |
| 3 months (days 0 to +63)so far, 14 of 64 days | −13.6% | −1.0% | −12.3% |
The abnormal return is the stock's return beyond what its usual relationship with the market (beta 1.00) predicts. A single stock's move can reflect other news on the same days, so it describes what happened rather than measuring the effect of the CEO change; averages across many events are on the Research design page as they are completed.
News coverage
- AngioDynamics Reiterates FY27 Outlook; Appoints Eric Honroth President And CEO ↗
rttnews.com · 8 October 2026 · Tone: neutral
Headlines from the day before the filing to three days after, found in the GDELT news index by company name, so an occasional match may be about something else. Tone is FinBERT's reading of the headline alone, a language model trained on financial news; it is not our view of the change.